Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
AstraZeneca
Cipla
Cantor Fitzgerald
Daiichi Sankyo
Boehringer Ingelheim
Healthtrust
Colorcon

Generated: April 22, 2018

DrugPatentWatch Database Preview

THEOCLEAR-100 Drug Profile

« Back to Dashboard

When do Theoclear-100 patents expire, and what generic alternatives are available?

Theoclear-100 is a drug marketed by Cent Pharms and is included in one NDA.

The generic ingredient in THEOCLEAR-100 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Drug patent expirations by year for THEOCLEAR-100
Synonyms for THEOCLEAR-100
1,3-dimethyl-1,3,7-trihydropurine-2,6-dione, hydrate
1,3-Dimethyl-1H-purine-2,6(3H,7H)-dione hydrate
1,3-Dimethylxanthine monohydrate
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, hydrate
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, monohydrate
5967-84-0
64790-23-4
7875AF
AC-12160
AC1L3LQJ
Accurbron (TN)
ACMC-20ajit
AEROLATE JR
AK307181
AKOS015960702
C137DTR5RG
C7H8N4O2.H2O
CAS-5967-84-0
CCG-220873
CHEMBL1355736
CTK2A2927
D06103
Dimethylxanthine
DTXSID40208361
FT-0694001
HE042776
HE255527
HE357969
HMS1570P07
HMS2097P07
I14-62379
KS-00000XPW
LS-176020
MFCD00151659
MolPort-002-339-588
NCGC00017052-01
Prestwick_1055
Quibron
Quibron Plus
SC-66614
SCHEMBL387338
ST50411853
Theo-Sav
THEOBID JR
THEOCLEAR L.A.-260
Theophylline (USP)
Theophylline [BAN:JAN]
Theophylline [USP:BAN:JAN]
THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER
THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
Theophylline monohydrate
Theophyllinemonohydrate
UNII-C137DTR5RG

US Patents and Regulatory Information for THEOCLEAR-100

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cent Pharms THEOCLEAR-100 theophylline TABLET;ORAL 085353-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Dow
Cerilliant
Fuji
Johnson and Johnson
US Department of Justice
Boehringer Ingelheim
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.